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Retinoic acid receptor (RAR) and retinoid X receptor are ligand-induced
transcription factors that belong to the nuclear receptor family. The
receptors are activated by small hydrophobic compounds, such as
all-trans-retinoic acid and 9-cis-retinoic acid, respectively. Interestingly,
these receptors are also targets for a number of exogenous compounds.
In this study, we characterized the biological activity of the 9-cis-
substituted retinoic acid metabolite, S-4-oxo-9-cis-13,14-dihydro-retinoic
acid (S-4o9cDH-RA). The endogenous levels of this metabolite in
wild-type mice and rats were found to be higher than those of all-
trans-retinoic acid, especially in the liver. Using cell-based luciferase
reporter systems, we showed that S-4o9cDH-RA activates the transcrip-
tion of retinoic acid response element-containing genes in several cell
types, both from a simple 2xDR5 element and from the promoter of the
natural retinoid target gene RARb2. In addition, quantitative RT-PCR
analysis demonstrated that S-4o9cDH-RA treatment significantly increases
the endogenous mRNA levels of the RAR target gene RARb2. Utilizing
a limited proteolytic digestion assay, we showed that S-4o9cDH-RA
induces conformational changes to both RARa and RARb in the same
manner as does all-trans-retinoic acid, suggesting that S-4o9cDH-RA is
indeed an endogenous ligand for these receptors. These in vitro results
were corroborated in an in vivo system, where S-4o9cDH-RA induced
morphological changes similar to those of all-trans-retinoic acid in the
developing chicken wing bud. When locally applied to the wing bud,
S-4o9cDH-RA induced digit pattern duplications in a dose-dependent
fashion. The results illustrate that S-4o9cDH-RA closely mimics all-
trans-retinoic acid with regard to pattern respecification. Finally, using
quantitative RT-PCR analysis, we showed that S-4o9cDH-RA induces
the transcription of several retinoic acid-regulated genes in chick wing
buds, including Hoxb8, RARb2, shh, Cyp26 and bmp2. Although
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Retinoids (vitamin A and its analogues) play essential
roles in several physiological processes, such as embry-
onic development, reproduction, immunity, prolifera-
tion, differentiation, apoptosis and vision (reviewed in
[1–5]). All-trans-retinoic acid (at-RA) is the most active
naturally occurring retinoid in mammals, except for
the visual process, where retinal is the active retinoid
form. In the body, at-RA is formed from its precursor
all-trans-retinol (at-ROL) following a series of revers-
ible and irreversible enzymatic steps (reviewed in
[3,6,7]). The biological effects of at-RA are mediated
by retinoic acid receptors (RARs) and retinoid X
receptors (RXRs) (reviewed in [8,9]). RARs and RXRs
are ligand-dependent transcription factors, which
belong to different subfamilies of the nuclear receptors
(I and II, respectively, according to the official nomen-
clature [10]). There are different RAR and RXR sub-
types (a, b and c), and each subtype exists in multiple
isoforms [11]. at-RA binds to the ligand-binding
domain of RARs, which induces heterodimer forma-
tion with RXRs to form the transcriptionally active
complex. The ligand–receptor–heterodimer complexes
act as transcriptional regulators of a multitude of
retinoid-regulated genes by binding to specific RA
response elements (RAREs) [9,12]. In addition to being
heterodimerization partners for RARs, RXRs can also
form RXR–RXR homodimers, and regulate the tran-
scription of certain genes via a retinoid X response
element (RXRE), characterized by a direct repeat-1
(DR-1) [9,12]. at-RA is responsible for the transcrip-
tional regulation of a multitude of genes, including one
of its own receptors: retinoic acid receptor b 2 (RARb2)
[13]. This regulation is critical for a number of biological
processes, including development and differentiation.
In particular, using developing chick bud as a model,
at-RA has been shown to be involved in several facets
of normal and abnormal embryogenesis (reviewed in
[14]). When at-RA is introduced into the anterior
margin of a chick limb bud, it evokes digit pattern
duplications in a dose-dependent fashion [15–17]. To
bring about these digit duplications, at-RA induces
effector genes that regulate limb development. Examples
of such genes are bone morphogen protein-2 (bmp2)
[18], various Hox genes [19–24] and sonic hedgehog
(shh) [21,25,26]. Cytochrome P450 26 (Cyp26; [27,28])
and RARb2 [22,23] are also locally induced in the limb
bud by exogenously applied at-RA, although their role
in normal limb development is not fully understood.
The diverse effects of RA action in controlling mis-
cellaneous cellular processes are thought to be orches-
trated by the multiplicity of retinoid metabolizing
enzymes and retinoid receptors [3]. The tissue- and cell
type-specific varieties of different possible receptor
combinations probably control very specific gene path-
ways influenced by these receptors. Furthermore, the
control of retinoid levels is critical, as too high and
too low cellular levels of at-RA can have deleterious
effects on the organism. Therefore, at-RA is normally
rapidly metabolized, which leads to the formation of
additional compounds. For example, at-RA is further
oxidized for degradation and excretion carried out by
three cytochrome P450 enzymes (CYP26 A1, B1 and
C1) [29–31]. One interesting question is whether the
different retinoid receptors are only activated by
at-RA, or whether other endogenous ligands exist,
which may regulate gene expression, possibly in a
receptor-selective fashion. Studies of retinoid
metabolism coupled to gene expression are therefore
important to identify novel pathways regulated by
noncharacterized active compounds.
Recently, we have isolated and characterized a hith-
erto unknown endogenous retinoid metabolite, which
is present in the liver of mice, rats and humans
(Fig. 1B,1) [32]. This metabolite was identified as
4-oxo-9-cis-13,14-dihydro-retinoic acid (S-4o9cDH-
RA), and is characterized by a chiral carbon at C13
(Fig. 1A,3). The identification of S-4o9cDH-RA in
several tissues of mice, rats and humans is remarkable,
as it is the first time a 9-cis-configured isomer of RA
has been detected endogenously in considerable con-
centrations. Indeed, some research groups have
reported the presence of 9-cis-RA (9c-RA [33]) or
other 9-cis-configured RA metabolites in vivo [34–36].
However, the concentrations of these metabolites were
much lower than that of at-RA. Moreover, the physio-
logical importance of 9c-RA and other 9-cis-configured
RA isomers is unclear. Although 9c-RA is known to
bind to different RXR isomers [37–41], it is currently
questionable whether it could actually be a physiologi-
cal ligand for RXRs. Two studies have concluded that
9c-RA is most unlikely to be an RXR-activating ligand
in vivo [42,43]. In contrast with 9c-RA, the endogenous
levels of S-4o9cDH-RA in serum, kidney and liver of
mice and rats were found to be high, reaching micro-
molar concentrations. In particular, the liver displayed
significantly larger amounts of this compound than of
S-4o9cDH-RA was less potent when compared with all-trans-retinoic acid,
the findings clearly demonstrate that S-4o9cDH-RA has the capacity to
bind and activate nuclear retinoid receptors and regulate gene transcrip-
tion both in vitro and in vivo.
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at-RA. In contrast with at-RA levels, which remain
strictly regulated, the endogenous levels of S-4o9cDH-
RA increased dramatically in the liver following vita-
min A supplementation in mice [32]. The physiological
relevance of these findings has not been elucidated.
The aim of this study was to investigate whether
S-4o9cDH-RA is a biologically active retinoid meta-
bolite, using different cell-based model systems and an
in vivo model. We found that S-4o9cDH-RA can
activate retinoid-dependent transcription in a dose-
dependent manner in both luciferase reporter assays
and endogenous genes. In addition, we demonstrated
evidence that S-4o9cDH-RA is a potential ligand for
at least two RAR subtypes, and induces conforma-
tional changes of the receptors in the same way as
does at-RA. Furthermore, we showed that exogenously
applied S-4o9cDH-RA mimics the patterning activities
of at-RA in the chick limb bud. Finally, using
quantitative RT-PCR analysis, we confirmed that
S-4o9cDH-RA can regulate the expression of several
at-RA target genes in the chick wing bud.
Results
S-4o9cDH-RA activates transcription of an
RA-responsive reporter gene construct
Previous experiments have shown that the S-4o9cDH-
RA metabolite is present at high levels in certain
tissues, such as the liver, kidney and serum (Fig. 1B,1)
[32]. In order to investigate whether S-4o9cDH-RA is
able to regulate gene transcription via the retinoid
receptors, three different cell lines were transfected
with a luciferase reporter plasmid under the regulation
of a minimal RARE, 2xDR5-luc. All three cell lines
express endogenous retinoid receptors, and are there-
fore suitable model systems for investigating retinoid-
dependent signalling. After transfection, cells were
treated with increasing doses of synthetic S-4o9cDH-
RA (Fig. 1B,3) or at-RA, included as a positive
control. Stably transfected HC11-RARE (mouse
mammary epithelium) cells, treated for 24 h with four
concentrations (10 nm to 10 lm) of S-4o9cDH-RA,
showed a dose-dependent increase in transcriptional
activity from the luciferase reporter (Fig. 2A); 1 lm of
S-4o9cDH-RA induced a significant 1.7-fold increase
in transcription compared with the untreated control,
and 10 lm resulted in a 2.4-fold increase (Fig. 2A,
lanes 5 and 6, respectively). A corresponding 3.2-fold
induction was observed in at-RA-treated cells (Fig. 2A,
lane 2). Similarly treated, but transiently transfected,
HeLa (human cervix carcinoma) cells showed a
two-fold increase in transcriptional activity following
S-4o9cDH-RA treatment at 1 lm (Fig. 2B, lane 6),
and treatment with at-RA led to a 3.7-fold increase
(Fig. 2B, lane 2). The luciferase activity at low concen-
trations of S-4o9cDH-RA was not significantly
induced in these cells. Finally, in P19 (mouse embry-
onic carcinoma) cells, even low doses of S-4o9cDH-
RA induced transcription weakly but significantly, and
10 lm led to a 2.8-fold increase (Fig. 2C, lane 7), com-
pared with a 6.8-fold increase following at-RA treat-
ment (Fig. 2C, lane 2). Taken together, S-4o9cDH-RA
is able to induce transcriptional activity dose
dependently. Although the effect of the metabolite was
not as potent as that of at-RA, the results were
A B
Fig. 1. Chemical structures and chromatograms of polar retinoids separated by reversed-phase HPLC. (A) Chemical structures of at-RA (1),
9c-RA (2) and S-4o9cDH-RA (3). (B) Chromatograms of polar retinoids separated by reversed-phase HPLC: 1, polar fraction of liver retinoids
from NRMI mice fed with normal diet containing 15 000 IU retinyl palmitateÆ(kg chow))1; 2, standard mixture consisting of several RA deriva-
tives [1, 4-oxo-13-cis-RA; 2, 4-oxo-all-trans-RA; 3, S-4o9cDH-RA; 4, RO101670 (IS, internal standard; all-trans-acitretin); 5, 3,4-didehydro-RA;
6, 13-cis-RA; 7, 9-cis-RA; 8, at-RA]; 3, aliquot of the synthetic S-4o9cDH-RA stock solution used for biological investigations. The 50 times
magnification of the signal demonstrates the 100% purity of the stock solution (RP18 column, Spherisorb ODS 2 mm, 2.1 · 150 mm, 3 lm
particle size; Waters, Eschborn, Germany).
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statistically significant. Next, we analysed the possi-
bility that S-4o9cDH-RA could have antagonistic or
synergistic effects on at-RA. To investigate this, P19
cells were transfected with the 2xDR5-luc reporter and
subsequently treated with at-RA alone (Fig. 2D, lane
2), or in combination with different doses of
S-4o9cDH-RA, ranging from 1 nm to 1 lm (Fig. 2D,
lanes 3–6). All treatments induced significant luciferase
reporter activity (P < 0.001) between 4.2- and 5-fold.
There were no significant differences in transcriptional
activity between the cells treated with at-RA alone and
the co-treated cells, suggesting that S-4o9cDH-RA has
neither antagonistic nor synergistic effects, at least in
P19 cells.
S-4o9cDH-RA induces transcription from the
natural RARb2 gene promoter
The results presented above suggest that S-4o9cDH-
RA can activate RAR ⁄RXR-dependent transcription
from a simple synthetic promoter. Next, we investi-
gated the ability of S-4o9cDH-RA to activate
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Fig. 2. Transcriptional activation of synthetic and natural RARE by S-4o9cDH-RA. HC11, HeLa and P19 cells (A–D) were transfected with a
luciferase reporter plasmid regulated by a minimal RARE in direct repeat 2xDR5, whereas Hepa1 cells (E, F) were transfected with a partial
region of the gene promoter from the natural retinoid target gene RARb2. Both sequences were cloned into a pGL3basic-luc vector (see
Materials and methods for details). As internal control, a vector expressing b-galactosidase was co-transfected. In all the transfection experi-
ments, the cells were transfected for 3 h with the indicated plasmid DNA, except for the stably transfected HC11-RARE cells (A). (A–C, E)
Transfected cells treated for 24 h with increasing concentrations of S-4o9cDH-RA (as indicated), together with at-RA (100 nM) as a positive
control. (D, F) P19 and Hepa1 cells double treated with at-RA and increasing concentrations of S-4o9cDH-RA for 24 h. The relative luciferase
induction is defined as a quotient of the luciferase levels of treated versus untreated samples. The presented results are the mean values
of three experiments carried out in duplicate. Statistical analyses are described in Materials and methods. Asterisks indicate significant
difference from untreated controls (Ctrl): *P < 0.05; **P < 0.01; ***P < 0.001. #No statistically significant difference between double versus
at-RA single treatment.
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transcription from a natural promoter. For this pur-
pose, we chose to use the RARb2 gene promoter in a
cell line of hepatic origin. Hepa-1 cells, which express
endogenous RAR and RXR isoforms, were transiently
transfected with the luciferase reporter plasmid pGL3b-
RARbluc, containing the natural RA-responsive part
of the RARb2 promoter. Following transfection, cells
were treated with S-4o9cDH-RA or at-RA as a positive
control. Luciferase reporter activity was induced 1.6-
fold compared with the controls following treatment
with 10 lm S-4o9cDH-RA (Fig. 2E, lanes 1 and 5),
whereas the lower concentrations of S-4o9cDH-RA
had no effect; at-RA-treated cells showed a 2.8-fold
increase (Fig. 2E, lane 2). Again, we investigated the
possibility of antagonistic or synergistic effects between
at-RA and S-4o9cDH-RA for activating the retinoid
receptors (Fig. 2F). Hepa-1 cells were transfected with
pGL3b-RARbluc and treated as the P19 cells in
Fig. 2D. In contrast with the results in P19 cells,
co-treatment with S-4o9cDH-RA resulted in a slight
increase in transcriptional activity (Fig. 2F, lanes 3–6).
However, as in Fig. 2D, the differences were not signi-
ficant. Hence, it is not possible to conclude whether
S-4o9cDH-RA has an antagonistic or synergistic effect
on at-RA-induced transcription.
S-4o9cDH-RA activates transcription via both
RARa and RARb
Next, we wanted to investigate whether S-4o9cDH-RA
displayed RAR isoform specificity. In tissues in which
the metabolite is found in high levels (liver, kidney),
RARa and RARb are predominantly expressed,
whereas RARc expression is mainly restricted to skin
[44]. Thus, we examined the transcriptional activation
of S-4o9cDH-RA via RARa and RARb. CV-1 cells
are devoid of retinoid receptors, except for small
amounts of RARa. This makes them a useful tool to
investigate whether S-4o9cDH-RA distinguishes
between certain combinations of retinoid receptor iso-
forms. CV-1 cells were transfected with plasmids
expressing a combination of either RARa and RXRb
or RARb and RXRb, together with the reporter plas-
mid 2xDR5-luc. The transfected cells were thereafter
treated with at-RA or S-4o9cDH-RA, as indicated in
Fig. 3A,B. S-4o9cDH-RA induced a dose-dependent
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Fig. 3. S-4o9cDH-RA transactivates 2xDR5
reporter via RARa ⁄RXRb or RARb ⁄RXRb
heterodimers, but fails to transactivate the
DR1 element via RXR homodimers in trans-
fected CV1 cells. CV1 cells were transiently
co-transfected with the reporter vector
pGL3basic2xDR5luc (A, B) or the DR1 ele-
ment (C, D), together with the expression
vectors for RARa and RXRb (A), RARa and
RXRb (B), RXRa (C) or RXRb (D). Cells were
treated with S-4o9cDH-RA at the indicated
concentrations. at-RA (100 nM) was used as
a positive control in (A) and (B), and 9c-RA
(100 nM) was used as a positive control in
(C) and (D). Cells were harvested after 24 h
of incubation to assay luciferase activity, as
described in Materials and methods. The
relative luciferase induction is defined as a
quotient of the luciferase levels of treated
versus untreated samples. The presented
results are the mean values of seven
experiments carried out in duplicate.
Statistical analyses are described in
Materials and methods: *P < 0.05;
**P < 0.01; ***P < 0.001.
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transactivation from the 2xDR5 reporter in the
presence of both of these combinations of retinoid
receptors (Fig. 3A,B). The lowest dose at which a
significant increase in transcriptional activation was
observed for the RARb ⁄RXRb combination was 10 nm
(Fig. 3B, lanes 4–7), and at 100 nm for the
RARa ⁄RXRb combination (Fig. 3A, lanes 5–7). At the
highest dose of S-4o9cDH-RA (10 lm), the fold changes
were 3.4- and 3-fold for the RARb ⁄RXRb and RARa ⁄
RXRb combinations, respectively, compared with 4.6-
and 6.1-fold after at-RA treatment. These results show
that S-4o9cDH-RA induced transcriptional activation
mediated by both of these combinations of retinoid
receptors.
To investigate whether S-4o9cDH-RA was able to
induce transcription via RXRa or RXRb homodimers,
CV-1 cells were transiently transfected with a luciferase
reporter containing an RXRE sequence (pGL3b-
DR1luc), together with expression vectors for RXRa
or RXRb (Fig. 3B,C). The cells were thereafter treated
with 9c-RA (as positive control) or S-4o9cDH-RA.
The results showed significant reporter activity in
response to treatment with 9c-RA, but not with
S-4o9cDH-RA, suggesting that S-4o9cDH-RA is
unable to activate transcription of either RXRa or
RXRb homodimers.
S-4o9cDH-RA induces endogenous RAR target
gene expression
So far, we have shown that S-4o9cDH-RA is able to
activate gene transcription via RAR on transfected
promoters. Next, we analysed the ability of this metab-
olite to activate endogenous gene expression. For this
purpose, P19 cells were treated with S-4o9cDH-RA or
at-RA for 2 and 24 h. Thereafter, the endogenous
mRNA levels of the RAR target gene RARb2 were
analysed using quantitative RT-PCR. After 2 h of
treatment, 1 and 10 lm S-4o9cDH-RA induced tran-
scription of endogenous RARb2 by approximately
two- and four-fold, respectively (Fig. 4A, lanes 3 and
4), compared with controls. For both the metabolite
and at-RA, the fold change increased significantly with
time. After 24 h of treatment with 10 lm S-4o9cDH-
RA, the RARb2 mRNA levels reached a 32-fold
increase (Fig. 4B, lane 4) and 1 lm S-4o9cDH-RA
resulted in a 3.2-fold increase (Fig. 4B, lane 3),
whereas at-RA-treated cells showed 61-fold induction
(Fig. 4B, lane 2). The results illustrate that S-4o9cDH-
RA is able to induce transcription of retinoid receptor
target genes.
S-4o9cDH-RA induces conformational changes of
both RARa and RARb
As S-4o9cDH-RA induced retinoid receptor-dependent
gene transcription, we wanted to investigate whether the
metabolite could bind to these receptors. Ligand bind-
ing to nuclear receptors induces a conformational
change of the receptor structure, which can be followed
using a limited proteolysis assay. The rationale of this
experiment is that unliganded and liganded receptors
will be degraded differently by proteolytic enzymes,
because alternative proteolytic epitopes are exposed as a
result of the conformational changes induced by the


































































Fig. 4. Induction of endogenous gene tran-
scription in P19 cells by S-4o9cDH-RA. P19
cells were simultaneously treated with 1
and 10 lM of S-4o9cDH-RA and incubated
for 2 h (A) and 24 h (B). As a positive con-
trol for RARb2 induction, cells were treated
in parallel with 100 nM at-RA as indicated.
PCR primers for RARb2 and c-actin were
used to analyse the endogenous levels of
RARb2 mRNA (see Materials and methods).
The RARb2 levels in the diagram were cal-
culated using the DCt method with c-actin
as endogenous control. The presented
results are the mean values ± standard error
of the mean (SEM) from three experiments.
Statistical analyses are described in Materi-
als and methods. Asterisks indicate signifi-
cant difference from controls: ***P < 0.001.
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generated from a protease-digested liganded receptor
than from an unliganded one. We investigated whether
the S-4o9cDH-RA metabolite had the ability to induce
a distinct conformational change in RARa and RARb
using limited proteolysis analysis. In these experiments,
[35S]methionine-labelled RARa and RARb were trans-
lated in vitro, incubated with retinoids and digested in
limited proteolysis reactions with trypsin. The labelled
receptors were incubated with 10 lm S-4o9cDH-RA or
100 nm at-RA, or the ethanol vehicle as control, and
then digested with trypsin. The results showed that
control-treated RARa and RARb produced a 25-kDa
fragment (Fig. 5A,B, lane 4). This fragment was not
detectable in samples in which RARa or RARb had
been preincubated with either at-RA or S-4o9cDH-RA
(Fig. 5A,B, lanes 5 and 6). In the presence of either
compound, the receptors demonstrated a different
digestion pattern compared with the controls, resulting
in the accumulation of a 30-kDa proteolytic fragment.
The results suggest that S-4o9cDH-RA binds directly to
both RARa and RARb, which, in turn, induces a
conformational change of the receptors that resembles
that induced by at-RA.
S-4o9cDH-RA alters digit development in a chick
embryo model
The observation that S-4o9cDH-RA acts similarly to
its parent compound at-RA in vitro prompted us to
test this metabolite in an in vivo model. To this end,
we used the developing chick wing bud model, a
classical model to measure RA action. In this model,
at-RA induces digit duplications in a dose-dependent
fashion. We analysed whether S-4o9cDH-RA had
similar effects on the digit pattern. Ion-exchange beads
were soaked in ethanolic solutions of S-4o9cDH-RA
at concentrations ranging from 0.2 to 10 mgÆmL)1,
and thereafter implanted in the anterior margin of
wing buds of Hamburger–Hamilton stage 20 chick
embryos. At concentrations of 0.2 and 0.5 mgÆmL)1,
the wing patterns were mostly normal (Fig. 6A,1) or
had an additional digit 2 (Fig. 6A,2). Patterns with
additional digits 3 and 4 (43234), in some cases with
truncations of digit 2 (4334), became most prevalent
when the soaking concentrations were equal to or
greater than 1 mgÆmL)1 (Fig. 6A,3, Table 1). Thus,
within a five-fold change in the soaking concentration,
there was a dramatic change in effect. The pattern of
additional digits was quantified as percentage respecifi-
cation values (see Materials and methods for a
definition), allowing the data to be plotted in a dose–
response curve (Fig. 6B). The efficacy of at-RA in the
limb pattern duplication assay has been extensively
documented (e.g. [16,17]). As can be seen in the dose–
response curves, the profile for S-4o9cDH-RA
(marked by filled circles) was shifted towards higher
soaking concentrations and did not reach the same
maximal response, indicating that this RA metabolite
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Fig. 5. S-4o9cDH-RA inhibits limited trypsin digestion of RARa and
RARb. In vitro-translated [35S]methionine-labelled RARa (A) and
RARb (B) samples were pre-incubated with ethanol alone (A, lanes
1 and 4; B, lanes 1 and 4) or together with 100 nM at-RA (A, lanes
2 and 5; B, lanes 2 and 5) or 10 lM S-4o9cDH-RA (A, lanes 3 and
6; B, lanes 3 and 6), followed by incubation with trypsin or buffer
only as indicated (for details, see Materials and methods). Samples
were separated by 10% SDS–PAGE ⁄ fluorography. For both RARa
and RARb, the 30 kDa proteolytic fragments (marked by a diamond)
of the receptors were protected from digestion by the presence of
either retinoid (A, lanes 5 and 6; B, lanes 5 and 6), in comparison
with the samples treated with ethanol only (A, lane 4; B, lane 4).
The 25 kDa fragments of the trypsin-digested receptors (marked by
a star) were only present in the samples treated as controls (etha-
nol; A, lane 4; B, lane 4).
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approximately 15. It should also be noted that
S-4o9cDH-RA did not evoke the loss of hand plate or
forearm elements, a result frequently seen with high
doses of at-RA (Table 1 and [17]). Thus, the novel
RA metabolite is less embryotoxic than at-RA.
Control bead implants immersed in ethanol had no
effect on the wing digit pattern (Table 1).
S-4o9cDH-RA induces the expression of
RA-regulated genes in the limb bud
To examine the regulation of genes involved in normal
limb development, beads soaked in 0.2 mgÆmL)1
at-RA or 2 mgÆmL)1 S-4o9cDH-RA were implanted in
the limb buds. These concentrations were selected
because they evoked pattern duplications to a similar
extent (about 90% respecification value) by the two
retinoids (Table 1; Fig. 7B). Transcript levels of the
direct at-RA target genes RARb2, Cyp26 and Hoxb8
were determined by quantitative RT-PCR in whole
buds removed after 6 h of retinoid treatment. Tran-
scripts of the indirect at-RA target genes shh and bmp2
were quantified in buds treated for 24 h, as their
induction by at-RA is known to occur only after pro-
longed treatment [18,21]. As endogenous shh is
expressed only in the posterior part of the limb bud
[25], buds were dissected into posterior and anterior
halves prior to RNA isolation, and induction was
assessed in both halves independently. bmp2 transcript
levels were also measured in both halves because, in
the Hamburger–Hamilton stages between 17 and 26,
the occurrence of bmp2 transcripts is also mostly
restricted to the posterior mesenchyme [18]. Transcript
levels of all investigated retinoid-regulated target genes
were increased significantly in limb bud tissue treated
with either retinoid (Fig. 7A–E); 2 mgÆmL)1 of
S-4o9cDH-RA induced RARb2, Cyp26 and Hoxb8 by
2.1-, 5.7- and 2.3-fold, respectively (Fig. 7A–C, lane 2),
and at-RA induced 2.3-, 8.9- and 2.2-fold changes,
respectively (Fig. 7A–C, lane 3). Thus, Hoxb8 expres-
sion was somewhat more induced by S-4o9cDH-RA
than by at-RA (Fig. 7C), whereas RARb2 and Cyp26
were slightly less induced by S-4o9cDH-RA than by
at-RA (Fig. 7A,B).
The indirect target genes bmp2 and shh were also
induced by both retinoids (Fig. 7D,E). In the anterior
limb bud half, bmp2 was significantly induced by
1.9-fold with S-4o9cDH-RA (Fig. 7D, lane 2) being
more efficient than at-RA (Fig. 7D, lane 3: 1.3-fold).
Endogenously, the expression of shh is restricted to the
posterior half of the limb buds. However, both
retinoids induced the expression of shh in the anterior
section. As there is no endogenous expression of shh in
the anterior tissue, the relative expression ratio (RER)
for shh (RERshh) in Fig. 7E is determined as a quotient
between at-RA- and S-4o9cDH-RA-treated samples.
By this criterion, at-RA induced shh six-fold more
strongly than did S-4o9cDH-RA. There was no differ-
ence found in the expression of target genes in
untreated limb bud samples and samples treated with
ethanol-soaked beads (data not shown). In conclusion,
S-4o9cDH-RA is able to control the expression of
genes involved in limb morphogenesis, such as shh
[25], Hoxb8 [19,20] and bmp2 [18], and likewise induces
the expression of direct at-RA-regulated target genes,
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Fig. 6. Effect of different doses of locally applied S-4o9cDH-RA (circles) and at-RA (triangles) on the chick wing pattern and dose–response
curves. (A) Beads were soaked in ethanolic S-4o9cDH-RA solution and implanted at the anterior margin of the right wing buds of stage 20
chick embryos. The images display the most frequent wing digit patterns of the chick embryos in the different treatment groups. 1, Normal
234 pattern (untreated control and soaking concentration of 0.2 mgÆmL)1; 2, 2234 pattern (concentration, 0.5 mgÆmL)1); 3, 43234 pattern
(concentration, 1 mgÆmL)1). Digit identities 2, 3, 4 are read from anterior to posterior; additional digits are marked by asterisks. (B) The per-
centage respecification value (PRV) was plotted against the soaking concentration and is a measure of the extent of pattern duplication (for
definition, see Materials and methods). PRV is an average value of each set. The sum of the scores of each wing is divided by the number
of limbs in each set.
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Discussion
The number of identified endogenous retinoid receptor
ligands in plasma and ⁄or soft tissues of various spe-
cies, including humans, is limited. Over recent years,
several studies have been published that have aimed
to discover novel endogenous RA metabolites with
receptor binding affinity by providing retinoids exoge-
nously [34,36,45]. For example, Shirley et al. [36]
described the reduction of 9c-RA to 9-cis-13,14-
dihydro-RA in rat plasma after the administration of
9c-RA, and Moise et al. [45] reported the occurrence
of all-trans-13,14-dihydro-RA in the liver of transgenic
mice supplemented with retinyl palmitate. Recently,
we found endogenous levels of S-4o9cDH-RA in both
wild-type mice and rats fed with a standard labora-
tory diet, as well as in humans, with high levels being
present primarily in the liver, but also in other tissues
[32].
The physiological role of oxidized RA metabolites is
not clearly understood. Although oxidation is generally
viewed to be the first step in the elimination pathway
for at-RA in vivo, it has been shown that the metabolite
4-oxo-all-trans-RA is a highly active modulator in
embryonic development [46]. Furthermore, 4-OH-all-
trans-RA, 4-oxo-all-trans-RA and 5,6-epoxy-all-trans-
RA are other oxidative metabolites that exhibit
significant biological activity in various types of cell
line [47–49]. These studies demonstrate a putative role
of retinoid metabolites in diverse biological processes.
However, a later study has provided genetic evidence
that oxidative RA metabolites are not required for
physiological retinoid signalling [50]. This study was
carried out on mice lacking CYP26A1, the enzyme that
Table 1. Digit patterns following local application of at-RA or S-4o9cDH-RA to stage 20 chick wing buds. PRV, percentage respecification
value.
Treatment Soaking concentration (mgÆmL)1) Embryos per group (n) Digit patterna Number of cases PRV
at-RA 0.025 12 234 (normal) 1 64
d234 1
dd234, dd234, d3234 3
43234, 43234 7
0.1 8 2234, 2234 4 67
43234, 43234 4
0.2 9 2234 1 93
43234 2
4334 6




S-4o9cDH-RA 0.2 8 234 (normal), d32 6 12
2234 2
0.5 7 234 (normal) 3 19
2234, d234 4




2.5 9 2234 1 85
dd234 1
4d234 1
43234, 43234, 43234 6
5 11 2234, 2234 2 88
43234, 43234, 43234 7
4d234 1
43d234 1
10 13 dd234 2 90
43234, 43234 10
4334 1
Ethanol 8 234 (normal) 8 0
a Digit identities are read from anterior to posterior; digits which are not clearly identifiable are marked as ‘d’; digits which are proximally
fused are shown in italic.
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metabolizes at-RA into more polar hydroxylated and
oxidized derivatives. The mice display severe develop-
mental abnormalities, for example spina bifida, which
theoretically could result either from an excess of
at-RA caused by a lack of tissue-specific catabolism, or
from a lack of signalling by bioactive RA metabolites,
such as 4-oxo-all-trans-RA. The authors demonstrated
that the former is the case, as these mice were pheno-
typically rescued by heterozygous disruption of the
RA-synthesizing enzyme, retinal dehydrogenase 2, i.e.
by reducing the at-RA levels. This study illustrates the
importance of tightly regulating at-RA levels in the
body. This can also be achieved by circumventing
at-RA synthesis from its precursor at-ROL, which has
been demonstrated to occur in mice [45]. Mice deficient
in lecithin:retinol acyltransferase, an enzyme involved
in the esterification and storage of at-ROL [51], showed
increased levels of 13,14-dihydro-retinoids after the
administration of high retinyl palmitate contents in the
diet [45]. Thus, the formation of 13,14-dihydro-retinoid
metabolites, such as S-4o9cDH-RA, could be a further
degradation pathway to protect the body against phar-
macological doses of at-ROL as a result of fluctuations
in nutritional vitamin A (predominantly at-ROL)
levels, under circumvention of the formation of at-RA.
This could be an explanation of the strongly increasing
S-4o9cDH-RA and relatively stable at-RA levels in


















































































Fig. 7. Transcript levels of RA-induced genes in limb bud tissue. Transcript levels of direct at-RA target genes (A–C, RARb2, Cyp26, Hoxb8)
and indirect at-RA target genes (D, E, bmp2, shh) induced in limb buds treated with S-4o9cDH-RA or at-RA. Beads were soaked in a solution
of 2 mgÆmL)1 S-4o9cDH-RA or 0.2 mgÆmL)1 at-RA, respectively. Absolute expression levels were determined by the standard curve method
(see Materials and methods). RER values of target genes were normalized to TBP (target gene ⁄ TBP). (A–D) Transcript levels, expressed as
RERs, of treated buds were compared with the endogenous expression levels of the appropriate genes in untreated buds (Ctrl). (E) RERshh
was determined as a quotient between at-RA- and S-4o9cDH-RA-treated samples (see Materials and methods). The presented results are
the mean values of three experiments carried out in duplicate. Statistical analyses are described in Materials and methods. Asterisks indicate
significant difference from controls (Ctrl): *P < 0.05; **P < 0.01; ***P < 0.001.
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Nevertheless, the enzymatic pathways responsible for
the formation of S-4o9cDH-RA and the possible precur-
sor retinoids are not known. The metabolism of vitamin
A is a highly regulated process, which includes conjuga-
tion, decarboxylation, oxidation, double bond isomeri-
zation and reduction, carried out by a well-organized
interplay of enzymes, as well as inter- and extracellular
retinoid binding proteins [3]. A novel enzyme, described
in mice [52], could possibly catalyse the key step in
the formation of 13,14-dihydro-RAs. All-trans-retinol :
13,14-dihydroretinol saturase converts at-ROL to
at-DH-ROL. Likewise, it has been demonstrated that
the same enzymes involved in the oxidation of at-ROL
to at-RA and then to oxidized RA metabolites can also
catalyse the oxidation of the corresponding dihydro-
metabolite at-DH-ROL to oxidized dihydro-RAs [45].
These synthesizing and metabolizing enzymes are invol-
ved in the combined regulation of desirable at-RA levels,
and could likewise be involved in the formation of
S-4o9cDH-RA under certain physiological circum-
stances. However, this potential metabolic pathway is
not sufficient to explain why S-4o9cDH-RA is 9-cis-
configured.
At present, the physiological role of 9c-RA is still
unclear. 9c-RA is normally undetectable in mammals,
except when vitamin A is present in excess [42,53],
although it can potentially be synthesized by presently
known enzymes, or derived from isomerization of
at-RA [54]. Heymann et al. [33] reported the occurrence
of relative high 9c-RA levels in the liver and kidney of
untreated wild-type mice. However, these findings could
not be reproduced by other laboratories. In an earlier
study, we reported, for the first time, detectable
amounts of 9c-RA and 9,13-di-cis-RA in human
plasma, but only after consumption of liver or vitamin
A supplementation [53]. However, the plasma levels of
9c-RA after liver consumption decreased within a few
hours to levels at or below the analytical detection limit.
It is still unclear whether 9c-RA is present endogenously
in mammalian blood or tissue, including the embryo. If
at all, the concentrations appear to be very low. Consid-
ering these facts, the role of 9c-RA in retinoid signalling
pathways as a putative RXR ligand is difficult to evalu-
ate. 9c-RA may rather play a pharmacological than a
physiological role as an RXR ligand [3].
The finding that a 9-cis-configured metabolite –
S-4o9cDH-RA – occurs endogenously and, moreover,
at high levels, which fluctuate depending on the retinol
intake, prompted us to examine whether S-4o9cDH-
RA plays a physiologically relevant role in retinoid
signalling. Data from preliminary molecular modelling
calculations suggest that S-4o9cDH-RA could act as a
potential ligand for both RXR and RAR receptors, as
its three-dimensional structure and geometry can adopt
a conformation which fits the ligand binding pockets
of the two receptors (M. Stefan, unpublished results).
In this study, we confirmed that S-4o9cDH-RA can
activate transcription via RAR–RXR heterodimers,
whereas the metabolite cannot induce transcriptional
activity of either RXRa or RXRb. We have shown
that S-4o9cDH-RA can activate gene transcription via
the retinoid receptors in a similar fashion as at-RA,
although to a lesser extent. As a result of the ascer-
tained purity of the synthetic S-4o9cDH-RA used in
the experiments, it can be excluded that the effects
were falsified by any other active RA.
S-4o9cDH-RA was able to activate transcription in
the presence of two different combinations of retinoid
receptors, suggesting that it displays no apparent iso-
form selectivity for RARa or RARb. As RARc expres-
sion is mainly restricted to skin [44], and the primary
occurrence of S-4o9cDH-RA is restricted to the liver,
we focused our study on the a and b isoforms. In addi-
tion to its transcriptional effects, S-4o9cDH-RA
induced conformational changes in both RARa and
RARb in a limited proteolysis assay in the same manner
as at-RA. Taken together, these observations indicate
that S-4o9cDH-RA functions as a bona fide ligand for
both RARa and RARb and hence activates RAR-
dependent gene transcription. Our data provide no
indication that S-4o9cDH-RA possesses either antago-
nistic or synergistic effects towards those of at-RA.
Using the chicken limb bud model, we demonstrated
that S-4o9cDH-RA is biologically active and induces
morphological changes similar to those reported for
at-RA [15–17,55,56]. It has been proposed that the role
of at-RA during the complex interactions and morpho-
genetic processes in limb development is a result of the
initiation of a cascade of events involving signalling
molecules, which bring about the formation of addi-
tional digits, when expressed together [21]. The
assumption that S-4o9cDH-RA provokes digit dupli-
cation in the same way as at-RA is supported by our
finding that S-4o9cDH-RA can control the expression
of several genes involved in limb morphogenesis,
including shh [25], Hoxb8 [19,20] and bmp2 [18]. In
addition, S-4o9cDH-RA induces the expression of
RARb2, Cyp26 and Hoxb8, which are known to be
direct retinoid target genes [57–60].
Our in vitro and in vivo data suggest that S-4o9cDH-
RA is an activator for retinoid-dependent signal trans-
duction, although less potent than at-RA when using
solution concentrations as a reference value. There are
several explanations for the comparatively lower efficacy
of the metabolite. An apparent explanation is the lower
binding affinity and thus transactivational capacity of
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S-4o9cDH-RA. However, it is difficult to draw this
conclusion because the metabolic stability of S-4o9cDH-
RA is not known. It is possible that at-RA is more meta-
bolically stable in the systems used in this study, and
thus the actual tissue concentrations of S-4o9cDH-RA
and at-RA are comparable. Therefore, the difference
in metabolic clearance may account for the difference in
efficacy in the present study. To gain further information
about the metabolic stability of S-4o9cDH-RA, it will
be necessary to measure the clearance of S-4o9cDH-RA
in comparison with at-RA using radiolabelled com-
pounds. Furthermore, in our previous study, we showed
that the concentration of S-4o9cDH-RA in mice liver
exceeded that of at-RA; thus, it is possible that, in the
organism, the metabolite reaches local concentrations
that are sufficient to activate RAR signalling.
From the results presented in this study, we suggest
that S-4o9cDH-RA is a biologically active retinoid
metabolite that may have gene regulatory functions
under physiological conditions. However, in order to
establish the physiological role of S-4o9cDH-RA,
further studies are necessary. It is important to under-
stand the formation and degradation of S-4o9cDH-
RA. The use of recombinant enzymes and siRNA
against enzymes possibly involved in the formation of
S-4o9cDH-RA could be a suitable technique to recon-
stitute the pathway of the new metabolite in vitro.
Knockout animals, deficient in certain enzymes
involved in the metabolism of retinoids, could also be
an appropriate way to answer these questions in vivo.
Likewise, it needs to be determined whether
S-4o9cDH-RA has specific biological roles other than
those similar to at-RA. Interestingly, the hepatic levels
of S-4o9cDH-RA increase drastically as a consequence
of a high retinyl palmitate content in the diet. A similar
correlation to dietary intake was not seen for at-RA,
for which the levels are very strictly regulated. Tissue
levels of S-4o9cDH-RA are most likely similarly
influenced by dietary vitamin A intake in humans,
suggesting a specific role of S-4o9cDH-RA in retinoid-
dependent gene regulation directly connected to dietary
intake, which has not been demonstrated for at-RA.
Materials and methods
Material
at-RA was purchased from Sigma-Aldrich (Steinheim,
Germany). S-4o9cDH-RA was synthesized according to a
developed enantioselective reaction series, which will be
published elsewhere. All retinoids used were diluted in etha-
nol. The stock solutions were regularly checked for purity
using reversed-phase HPLC analysis, as described previ-
ously [61]. Figure 1B demonstrates the chemical purity of
an aliquot of synthetic S-4o9cDH-RA (Fig. 1B,3) used in
the experiments, in comparison with a standard mixture of
several RA derivatives (Fig. 1B,2) separated by reversed-
phase HPLC. Prior to each experiment, retinoid stock solu-
tions were diluted in culture medium to the final exposure
concentration. All experimental procedures involving treat-
ment with retinoids were light-protected.
Plasmid constructs
The 2xDR5-luc reporter plasmid was constructed using two
copies of a consensus RARE (AGGTCAn5AGGTCA)
placed in front of a minimal TATA box and inserted into the
pGL3basic vector (Promega, Nacka, Sweden). The pGL3b-
RARb2luc reporter contains the natural RA-responsive
RARb2 gene promoter () 180 to + 83) inserted into the
pGL3basic vector. The plasmids expressing different retinoid
receptors (RARa and b, RXRa and b) have a pSG5
backbone.
Cell culture and transient transfections
Green monkey kidney cells (CV1), mouse embryonic carci-
noma cells (P19) and human cervix carcinoma cells (HeLa)
were routinely maintained in high-glucose Dulbecco’s modi-
fied Eagle’s medium (DMEM; Gibco Invitrogen, Carlsbad,
CA, USA) supplemented with 10% (v ⁄ v) fetal bovine serum
(Gibco Invitrogen), 1% (v ⁄ v) PEST (Gibco Invitrogen), 1%
(v ⁄ v) l-glutamine (Gibco Invitrogen) and 1% nonessential
amino acids (Gibco Invitrogen). Murine hepatoma-1 cells
(Hepa-1c1c7; Hepa-1) were grown in low-glucose DMEM
(Gibco Invitrogen) supplemented with 10% (v ⁄ v) fetal
bovine serum (Gibco Invitrogen), 1% (v ⁄ v) PEST (Gibco
Invitrogen), 1% (v ⁄ v) l-glutamine (Gibco Invitrogen) and
1% (v ⁄ v) pyruvate (Gibco Invitrogen). Mouse mammary epi-
thelial cells (HC11) were grown in RPMI 1640+ medium
(Gibco Invitrogen) supplemented with 1% (v ⁄ v) gentamicin
(Gibco Invitrogen), 1% (v ⁄ v) l-glutamine, 5 lgÆmL)1 insulin
(Gibco Invitrogen), 10 ngÆmL)1 epidermal growth factor
(Gibco Invitrogen) and 240 lgÆmL)1 Geneticin (G418;
Gibco Invitrogen). P19 cells were grown on culture plates
pre-treated with 0.1% gelatin (w ⁄ v in water). The day before
transfection, cells were seeded on 12- or 24-well culture
plates. Transient transfections were performed using lipofec-
tamineTM and Plus Reagent (Invitrogen, Carlsbad, CA,
USA), according to the manufacturer’s protocol, in serum
and antibiotic-free media. Briefly, each well received 100 ng
of reporter plasmid (as indicated in the figure legends) and
20 ng of a CMV-b-galactosidase expressing plasmid (serving
as an internal control for transfection efficiency) and, in the
case of CV1 cells, 5–20 ng of expression plasmids for RARa,
RARb, RXRa or RXRb as indicated. After 3 h, media
containing serum and retinoids (1 nm to 10 lm S-4o9cDH-
RA; 100 nm at-RA and 9c-RA) were added and the cells
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were incubated for 24 h, when the media were removed and
the cells were harvested. Luciferase activity was measured
using a Luciferase assay kit (BioThema AB, Haninge,
Sweden), according to the manufacturer’s instructions,
employing an automated luminometer (Lucy 3; Anthos Lab-
tec Instruments, Salzburg, Austria). b-Galactosidase activity
was determined using the Tropix Galacto-Light Plus chemi-
luminescence assay system (Tropix, Bedford, MA, USA),
according to the manufacturer’s protocol. Data are presented
as the mean ± standard deviation (SD) of relative luciferase
activity corrected for the internal standard of, in each case,
at least three experiments performed in duplicate.
Stable transfections
For stable transfections, HC11 cells were grown in 10-cm
plates and transfected with 10 lg of the pGL3b-2xDR5luc
reporter plasmid using lipofectamineTM reagent (Invitro-
gen). Stable clones were selected in 240 lgÆmL)1 geneticin
in RPMI 1640 medium.
Induction of RARb2 mRNA in P19 cells
P19 cells were allowed to aggregate on six-well plates for
1 day before the start of each experiment. The subsequent
incubation with the indicated retinoids was then terminated
at the indicated time points by washing with NaCl ⁄Pi and
lysis of the cells using 1 mL of Trizol (Invitrogen) per well.
Total RNA from the cells was extracted according to the
manufacturer’s protocol. In order to eliminate genomic
DNA, 2 g of total RNA from each extracted sample was
treated with DNaseI (Invitrogen) before cDNA synthesis
(SuperScriptII; Invitrogen). Quantitative real-time PCR was
performed using Power CyberGreen MasterMix (Applied
Biosystems, Foster City, CA, USA) in a total volume of
12 L, including 2 L of cDNA template diluted five times in
water, and 300 nm of forward and reverse primer. ABI Prism
7500 Fast Sequence Detection System instrument and soft-
ware (v1.3) (Applied Biosystems) were used to amplify and
analyse specific mRNA expression, with a reaction profile of
95 C for 10 min, followed by 40 cycles of 95 C for 15 s and
60 C for 60 s. A dissociation curve analysis was added to
each run in order to trace artefacts in individual samples.
Each cDNA template was analysed in duplicate and the
results represent three separate experiments. The forward
and reverse PCR primers for RARb2 and c-actin have been
published elsewhere [62].
Limited proteolytic digestion of
in vitro-translated receptors
[35S]Methionine (Amersham Biosciences AB, Uppsala,
Sweden)-labelled mouse RARa and RARb proteins were
synthesized in vitro using the coupled rabbit reticulocyte
lysate cell-free system (Promega), according to the instruc-
tions provided by the manufacturer, using the expression vec-
tors pSG5-RARa and pSG5-RARb as templates. Aliquots
of reticulocyte lysates containing [35S]methionine-labelled
RARa or RARb were incubated with 100 nm at-RA or
10 lm S-4o9cDH-RA for 45 min at 30 C. Controls were
incubated with vehicle (0.05% ethanol). To 5 lL aliquots of
retinoid-treated receptor proteins, 4 lL of trypsin (Promega)
dissolved in 50 mm acetic acid buffer was added and incu-
bated for 10 min at 25 C. The reaction was stopped by the
addition of 6 lL of 5 · SDS loading buffer containing
500 lm EDTA and boiling of the samples for 5 min prior to
separation on 10% (w ⁄ v) SDS-polyacrylamide gels. For fixa-
tion of the proteins, the gels were soaked in 25% isopropyl
alcohol and 10% acetic acid aqueous solution for 30 min,
followed by Amplify (Amersham) for 30 min. After drying,
the gels were autoradiographed overnight at ) 80 C.
Local application of RA to chick embryos
Fertilized White Leghorn chicken eggs (VALO specified
pathogen-free eggs; Lohmann Tierzucht, Cuxhaven,
Germany) were incubated at 37.5 C and a humidity of
approximately 60%. After 65 h of incubation in a horizontal
orientation, eggs were windowed, and embryos were staged
according to Hamburger & Hamilton [63]. Approximately 15
AG1-X2 ion-exchange beads (Bio-Rad, Richmond, CA,
USA) (diameter, 200–250 lm) were placed by forceps into a
1.5 mL microcentrifuge polypropylene tube and soaked in
30 lL ethanolic solution containing the retinoids. The soak-
ing concentration for at-RA ranged from 25 to 500 lgÆmL)1
for limb duplication experiments and 200 lgÆmL)1 for gene
expression analysis. The soaking concentration for
S-4o9cDH-RA was 0.2–10 mgÆmL)1 for limb duplication
experiments and 2 mgÆmL)1 for gene expression analysis.
Control beads were soaked in ethanol alone. The microcen-
trifuge tubes containing beads were vigorously shaken in a
microtube shaker for 20 min at room temperature. After
removing the retinoid solution, the beads were washed twice
for 20 min in 200 lL of phenol red-containing phosphate-
buffered saline (100 mL NaCl ⁄Pi and 500 lL of a 2 mgÆmL)1
phenol red solution in ethanol). Beads were then implanted
using watchmaker’s forceps (type 5) underneath the apical
ectodermal ridge at the anterior margin of the right limb bud
of a Hamburger–Hamilton stage 20 chick embryo (for
details, see [17]). The eggs were sealed with tape and returned
to the incubator for either 6 or 24 h for gene expression anal-
ysis and 7 days for analysis of wing patterns.
Analysis of wing patterns and dissection of limb
bud tissue
After 7 days of incubation, embryos were sacrificed, washed
three times in water, fixed in 5% (w ⁄ v) trichloroacetic acid
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(Roth, Karlsruhe, Germany), stained in Alcian blue dye
(Sigma-Aldrich, Steinheim, Germany) solution [0.5 g of dye
in 500 mL of 70% (v ⁄ v) ethanol containing 1% HCl], dif-
ferentiated in acidic ethanol (70% ethanol containing 1%
HCl) and cleared with methyl salicylate (Sigma-Aldrich). In
order to generate dose–response curves that quantitatively
reflect the effects, the extent of pattern duplication was sta-
ted in percentage respecification values, in which the wing
patterns were expressed in numerical terms. Patterns were
scored as follows: a pattern with the anterior-most addi-
tional digit being a digit 4 scored 100%; a wing with an
additional digit 3 anteriorly scored 66%; a wing with an
additional digit 2 scored 33%; a digit of equivocal identity
obtained a score of 0%. For the analysis of limb buds,
embryos were dissected out of the egg after 6 and 24 h of
incubation and rinsed in ice-cold NaCl ⁄Pi. The buds were
cut off with small scissors. Whole buds were used from the
6 h time point, whereas buds from the 24 h time point were
cut into anterior and posterior parts using a fine tungsten
needle. For each time point, three buds were pooled, and
experiments were carried out in triplicate. Dissected buds
were collected in microcentrifuge vials and immediately
rinsed in a tissue disruption buffer (RNeasy, Qiagen,
Hilden, Germany).
RA target gene expression analysis in limb tissue
Total RNA was extracted and purified using a universal tis-
sue RNeasy Kit (Qiagen), according to the manufacturer’s
instructions. Total RNA was reverse transcribed (Thermo-
ScriptTM RT-PCR-System; Invitrogen) using oligo-(dt)20
primers, as described in the protocol provided. To limit vari-
ations, all RNA samples were reverse transcribed isochronal.
Quantitative RT-PCR was performed on an iCyclerTM (Bio-
Rad, Hercules, CA, USA) in 20 lL reaction mixtures with
350 nm of each primer and iQ SYBRGreen Supermix (Bio-
Rad, Munich, Germany), following the manufacturer’s
instructions. Real-time PCR conditions consisted of an initial
denaturation step at 95 C for 10 min, followed by 50 cycles
of denaturation for 15 s at 94 C, annealing for 25 s at 60 C
and extension for 20 s at 72 C, with a single fluorescence
measurement. The specificity of the quantitative RT-PCR
products was determined by performing melting curve analy-
sis after each PCR from 50 to 94 C with an increasing set
point temperature after cycle 2 by 0.5 CÆs)1 and continuous
fluorescence measurement. Oligonucleotide primers specific
for Hoxb8 (sense, 5¢-CTACCAGACGCTGGAACTGG;
antisense, ACCTGCCTTTCTGTCAATCC), Cyp26 (sense
5¢-CTTTCAGTGGGCTCTACCG; antisense, GCAGTGC
ATCCTTGTAGCC), RARb2 (sense, 5¢-GCATGCTTCAGT
GGATTGG; antisense, AGTGGTGAAGGAGGGCTTG),
shh (sense, 5¢-GGCCAGTGGAAGATATGAAGG; anti-
sense, GCATTCAGCTTGTCCTTGC), bmp2 (sense, 5¢-CC
TACATGTTGGACCTCTATCG; antisense, AAACTTCTT
CGTGGTGGAAGC) and TATA box binding protein
(TBP) (sense, 5¢-CTGGCAGCAAGGAAGTACG; anti-
sense, GCTCATAGCTGCTGAACTGC) were designed
using the software Primer3 and optimized to an annealing
temperature of 60 C. TBP is a housekeeping gene that
should be equally expressed in all cells and was used as an
internal standard. Expression levels of target genes were
determined by the standard curve method. The standard
curve of each target gene was obtained with coincidental
samples over 3.5 log levels on each plate. The absolute quan-
tity of target RNA was determined by icycler iq optical
software (Bio-Rad, Hercules, CA, USA). The expression
level of each target gene was normalized by dividing it by
the TBP expression level. RER of each target gene is defined
as a quotient between treated and untreated samples, based
on the absolute quantity levels, and is expressed in arbitrary
units (RER = [absolute target gene quantitytreated sample
(absolute quantitytarget gene ⁄ absolute quantityTBP)] ⁄ [absolute
target gene quantityuntreated sample (absolute quantitytarget
gene ⁄ absolute quantityTBP)]). As shh is a gene which is not
expressed endogenously in the anterior section of the limb
buds, RER for shh (RERshh) was determined as a quotient
between at-RA- and S-4o9cDH-RA-treated samples
(RERshh = [absolute shh quantityat-RA-treated sample (abso-
lute quantityshh ⁄ absolute quantityTBP)] ⁄ [absolute shh quan-
tityS-4o9cDH-RA-treated sample (absolute quantityshh ⁄ absolute
quantityTBP)]). The reported data are the arithmetic
mean ± SD for individual groups of different treatments.
All statistical analysis was assessed using sigmastat statisti-
cal software (Jandel Scientific, Erkath, Germany). When the
data were normally distributed (Kolmogorov–Smirnov test),
the paired t-test was used to test statistically significant
differences between controls and treated samples. The level
of significance was selected as P < 0.05. Group sizes are
indicated in the table and figures.
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